INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,947,254 | -4.7% | 61,583 | +23.2% | 0.00% | 0.0% |
| Q2 2023 | $2,043,691 | +135693.4% | 49,968 | +19.5% | 0.00% | 0.0% |
| Q1 2023 | $1,505 | -34.5% | 41,800 | -36.5% | 0.00% | -33.3% |
| Q4 2022 | $2,298 | -99.9% | 65,864 | +1.6% | 0.00% | -50.0% |
| Q3 2022 | $3,586,000 | +9.8% | 64,845 | +4.1% | 0.01% | +20.0% |
| Q2 2022 | $3,266,000 | +62.7% | 62,276 | +124.1% | 0.01% | +150.0% |
| Q1 2022 | $2,007,000 | -29.2% | 27,795 | +19.0% | 0.00% | -50.0% |
| Q4 2021 | $2,833,000 | -42.9% | 23,357 | -35.2% | 0.00% | -33.3% |
| Q3 2021 | $4,959,000 | -36.0% | 36,049 | -29.4% | 0.01% | -53.8% |
| Q2 2021 | $7,743,000 | +143.2% | 51,072 | +15.9% | 0.01% | +160.0% |
| Q1 2021 | $3,184,000 | – | 44,072 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |